Mounjaro Weight Loss Injections in Malaysia
Mounjaro (tirzepatide) is a weekly injectable dual GIP and GLP-1 receptor agonist clinically proven to reduce body weight by up to 22.5% in adults with obesity or excess weight.
Mounjaro is a once-weekly injection used to support weight management and blood sugar control. At Vivardi Clinics in Rawang, it is prescribed and monitored by our doctors as part of a wider plan that includes diet, activity and ongoing review.
What Is Mounjaro?
Mounjaro (tirzepatide) is a once-weekly injectable medication that helps regulate appetite and blood sugar. It can support meaningful weight management and is also used in the management of type 2 diabetes. It works best alongside healthy eating and activity, and needs the right dose and monitoring, so it should always be prescribed by a doctor after a proper assessment.
- Once-weekly injection
- Supports appetite control
- Works with diet and lifestyle
- Doctor-prescribed and monitored
Benefits
Appetite support
Helps regulate appetite alongside healthy habits.
Simple routine
A single weekly injection.
Doctor-led
Prescribed and reviewed by a qualified doctor.
What to Expect
Consultation
The doctor reviews your health, goals and history.
Prescription
If suitable, Mounjaro is prescribed at a starting dose.
Weekly use
You inject weekly, with the dose increased gradually.
Review
Progress and any side effects are monitored over time.
Results and Expectations
Weight management with Mounjaro is gradual and works best as part of a sustainable plan. The dose is usually increased slowly to help reduce side effects such as nausea. Results vary from person to person, and ongoing support from your doctor helps you stay on track, manage side effects and adjust the plan as needed. It is a medical treatment, not a quick fix, and is most effective alongside healthy eating and activity.
Prescribed by Qualified Doctors
Safe, monitored weight management
Mounjaro needs the right dose, monitoring and lifestyle support to be safe and effective. At Vivardi, an LCP-certified doctor assesses your suitability, prescribes appropriately and reviews your progress. Every consultation is private and handled in line with Malaysia's PDPA.
Mounjaro FAQ
How is Mounjaro taken?
Do I need a prescription?
Are there side effects?
How fast will I see results?
Is it only for diabetes?
Is my visit private?
Who should not take Mounjaro?
Do I inject it myself?
Will the weight return if I stop?
Who Mounjaro Suits
Mounjaro is generally considered for adults working towards meaningful weight management, often those with a higher body mass index or weight-related health concerns, and it is also used in the management of type 2 diabetes. It suits people who are ready to pair the medication with changes to eating and activity, since it supports a healthier lifestyle rather than replacing it. It is not appropriate for everyone: it should not be used in pregnancy, and certain medical histories, such as particular thyroid conditions or pancreatitis, need to be ruled out first. As a prescription medication, it is only started after a doctor reviews your health, medications and goals to confirm it is safe and suitable.
Starting Treatment and Monitoring
If Mounjaro is suitable, the doctor starts you on a low dose given as a once-weekly injection under the skin, which you can usually give yourself after guidance. The dose is increased gradually over the following weeks, which helps reduce common early side effects such as nausea. Weight management is steady rather than instant, and works best alongside a balanced diet and regular activity. Throughout treatment your doctor monitors your progress, weight and any side effects, and adjusts the plan as needed. Because the medication supports appetite control while you take it, your doctor will also talk through how to maintain your results over the longer term.
Start a Supported Plan
Book a private consultation at Vivardi Clinics in Rawang to see if Mounjaro is right for you.
Is Mounjaro available in Malaysia and how does it work?
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist available via private prescription in Malaysia. Unlike semaglutide (Ozempic/Wegovy/Rybelsus), Mounjaro activates two gut hormone pathways simultaneously, making it significantly more effective for weight loss. Clinical trials (SURMOUNT programme) showed average weight reduction of 15–22.5% of body weight over 72 weeks — the highest weight loss efficacy recorded for any approved weight loss medication to date.
How does Mounjaro differ from Ozempic or Rybelsus?
All three medications are injectable GLP-1-based weight loss treatments — with a key distinction for Mounjaro. Ozempic and Rybelsus (semaglutide) activate only the GLP-1 receptor. Mounjaro (tirzepatide) additionally activates the GIP receptor, which works synergistically to reduce appetite more powerfully, improve insulin sensitivity further, and promote greater fat loss. In head-to-head trials, Mounjaro produces significantly greater weight loss than semaglutide-based medications.
How much weight can I lose with Mounjaro?
In the SURMOUNT-1 clinical trial, participants without diabetes lost an average of 15.0% (5mg), 19.5% (10mg), and 20.9% (15mg) of their body weight over 72 weeks. Real-world results vary, but many patients achieve 15–25% weight reduction. A person weighing 90kg could expect to lose 13–23kg over the treatment period. Weight maintenance after stopping requires sustained lifestyle changes — ongoing treatment or transition to a lower-dose maintenance programme may be needed.
What are the side effects of Mounjaro?
The most commonly reported side effects are gastrointestinal: nausea, vomiting, diarrhoea, constipation, and reduced appetite — particularly during dose escalation. These typically improve after the first few weeks. Starting at the lowest dose (2.5mg) and increasing slowly every 4 weeks helps minimise side effects. Serious but rare risks include pancreatitis and, theoretically, thyroid C-cell tumours (based on animal studies). A full medical assessment is done before prescribing.
Do I need a prescription for Mounjaro in Malaysia?
Yes. Mounjaro is a prescription-only medication in Malaysia. At Vivardi Clinics, our doctors conduct a full metabolic assessment — including BMI, blood glucose, HbA1c, and medical history review — before prescribing Mounjaro. Regular monthly follow-ups are required to monitor weight, side effects, and metabolic markers throughout treatment. We also provide dietary guidance to maximise results during treatment.